In a HCC xenograft model, blockage of PI3K/AKT/HIF-1α signaling enforces the therapeutic efficacy of hypoxic chemotherapy (Jiao and Nan, 2012[10]). Here, AKT1 is linked to hepatocellular carcinoma.